A Spatiotemporal Analysis of Hemodialysis Incidence Rate and Impact of the COVID-19 Pandemic on the End-Stage Kidney Disease Trend
DOI:
https://doi.org/10.61882/ijkd.19.3.172Keywords:
Dialysis, ESKD, Spatiotemporal model, COVID-19 pandemicAbstract
Introduction. Limited research has been conducted on the spatial trend of end-stage kidney disease (ESKD), particularly hemodialysis (HD), in developing countries. This is problematic considering the growing demand for dialysis services in these regions. To bridge this research gap, this study evaluates the spatial trend of chronic dialysis incidence rates over a significant period (2007 to early 2021) in a large population, while also investigating the influence of the COVID-19 pandemic on this trend.
Methods. We used data from the Shiraz University of Medical Sciences Specific Diseases Affairs database (2007-2021) on 8,368 dialysis patients. A Bayesian spatiotemporal model analyzed the data to estimate ESKD trends and relative risks with hemodialysis in 29 counties.
Results. Among the patients receiving maintenance dialysis for end-stage kidney disease (ESKD), 3,348(40%) were female and 5,020(60%) were male. The average age was 57.58 ± 17, with a median age of 56 (2-98) years. The standardized incidence rate in 2007 was 0.78, while in 2020-21, it increased to 0.86. The estimated mean relative risk was 1.20, ranging from 0.43 to 4.35. We observed a consistent fixed trend with a coefficient of 0.99. During the COVID-19 pandemic and outside of it, we noticed an increased spatiotemporal interaction in the central and northern regions of the province, despite the temporal trend remaining relatively stable. Conclusion. Our study reveals previously unexplored geographic disparities in ESKD incidence within Fars province from 2007 to 2021. The notable increase in dialysis cases in the central and northern regions emphasizes the urgency of addressing this public health concern.
Downloads
References
1. Jager KJ, Kovesdy C, Langham R, Rosenberg M, Jha V, Zoccali C. A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Kidney Int. 2019;96:1048-50. doi: 10.1016/j.kint.2019.07.012. PubMed PMID: 31582227.
2. Foreman KJ, Marquez N, Dolgert A, Fukutaki K, Fullman N, McGaughey M, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet. 2018;392:2052-90. doi: 10.1016/s0140-6736(18)31694-5. PubMed PMID: 30340847; PubMed Central PMCID: PMCPMC6227505.
3. Webster AC, Nagler EV, Morton RL, Masson P. Chronic Kidney Disease. Lancet. 2017;389:1238-52. doi: 10.1016/s0140-6736(16)32064-5. PubMed PMID: 27887750.
4. Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385:1975-82. doi: 10.1016/s0140-6736(14)61601-9. PubMed PMID: 25777665.
5. Couchoud C, Guihenneuc C, Bayer F, Lemaitre V, Brunet P, Stengel B. Medical practice patterns and socio-economic factors may explain geographical variation of end-stage renal disease incidence. Nephrol Dial Transplant. 2012;27:2312-22. doi: 10.1093/ndt/gfr639. PubMed PMID: 22121236.
6. Desmarets M, Ayav C, Diallo K, Bayer F, Imbert F, Sauleau EA, et al. Fine-scale geographic variations of rates of renal replacement therapy in northeastern France: Association with the socioeconomic context and accessibility to care. PLoS One. 2020;15:e0236698. doi: 10.1371/journal.pone.0236698. PubMed PMID: 32722704; PubMed Central PMCID: PMCPMC7386572.
7. Kihal-Talantikite W, Deguen S, Padilla C, Siebert M, Couchoud C, Vigneau C, et al. Spatial distribution of end-stage renal disease (ESRD) and social inequalities in mixed urban and rural areas: a study in the Bretagne administrative region of France. Clin Kidney J. 2015;8:7-13. doi: 10.1093/ckj/sfu131. PubMed PMID: 25713704; PubMed Central PMCID: PMCPMC4310433.
8. Occelli F, Deram A, Génin M, Noël C, Cuny D, Glowacki F. Mapping end-stage renal disease (ESRD): spatial variations on small area level in northern France, and association with deprivation. PLoS One. 2014;9:e110132. doi: 10.1371/journal.pone.0110132. PubMed PMID: 25365039; PubMed Central PMCID: PMCPMC4217729.
9. KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 update. Am J Kidney Dis. 2015;66:884-930. doi: 10.1053/j.ajkd.2015.07.015. PubMed PMID: 26498416.
10. Garg AX, Suri RS, Eggers P, Finkelstein FO, Greene T, Kimmel PL, et al. Patients receiving frequent hemodialysis have better health-related quality of life compared to patients receiving conventional hemodialysis. Kidney Int. 2017;91:746-54. doi: 10.1016/j.kint.2016.10.033. PubMed PMID: 28094031; PubMed Central PMCID: PMCPMC5333984.
11. Moist LM, Bragg-Gresham JL, Pisoni RL, Saran R, Akiba T, Jacobson SH, et al. Travel time to dialysis as a predictor of health-related quality of life, adherence, and mortality: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2008;51:641-50. doi: 10.1053/j.ajkd.2007.12.021. PubMed PMID: 18371540.
12. Hill NR, Fatoba ST, Oke JL, Hirst JA, O'Callaghan CA, Lasserson DS, et al. Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis. PLoS One. 2016;11:e0158765. doi: 10.1371/journal.pone.0158765. PubMed PMID: 27383068; PubMed Central PMCID: PMCPMC4934905.
13. Xie Y, Bowe B, Mokdad AH, Xian H, Yan Y, Li T, et al. Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney Int. 2018;94:567-81. doi: 10.1016/j.kint.2018.04.011. PubMed PMID: 30078514.
14. Abraham G, Varughese S, Thandavan T, Iyengar A, Fernando E, Naqvi SA, et al. Chronic kidney disease hotspots in developing countries in South Asia. Clin Kidney J. 2016;9:135-41. doi: 10.1093/ckj/sfv109. PubMed PMID: 26798474; PubMed Central PMCID: PMCPMC4720189.
15. Strohbehn IA, Zhao S, Seethapathy H, Lee M, Rusibamayila N, Allegretti AS, et al. Acute Kidney Injury Incidence, Recovery, and Long-term Kidney Outcomes Among Hospitalized Patients With COVID-19 and Influenza. Kidney Int Rep. 2021;6:2565-74. doi: 10.1016/j.ekir.2021.07.008. PubMed PMID: 34307971; PubMed Central PMCID: PMCPMC8280679.
16. Geetha D, Kronbichler A, Rutter M, Bajpai D, Menez S, Weissenbacher A, et al. Author Correction: Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions. Nat Rev Nephrol. 2022;18:738. doi: 10.1038/s41581-022-00635-3. PubMed PMID: 36127498; PubMed Central PMCID: PMCPMC9487852.
17. Lumlertgul N, Pirondini L, Cooney E, Kok W, Gregson J, Camporota L, et al. Acute kidney injury prevalence, progression and long-term outcomes in critically ill patients with COVID-19: a cohort study. Ann Intensive Care. 2021;11:123. doi: 10.1186/s13613-021-00914-5. PubMed PMID: 34357478; PubMed Central PMCID: PMCPMC8343342.
19. Blangiardo M, Cameletti M. Spatial and spatio-temporal Bayesian models with R-INLA: John Wiley & Sons; 2015.
20. Asmarian N, Sharafi Z, Mousavi A, Jacques R, Tamayo I, Bind MA, et al. Multiple sclerosis incidence rate in southern Iran: a Bayesian epidemiological study. BMC Neurol. 2021;21:309. doi: 10.1186/s12883-021-02342-1. PubMed PMID: 34376167; PubMed Central PMCID: PMCPMC8353854.
21. Lawson AB. Bayesian disease mapping: hierarchical modeling in spatial epidemiology: Chapman and Hall/CRC; 2018.
22. Desktop EAJR, CA: Environmental Systems Research Institute. Release 10. 2011;437:438.
23. De Meyer V, Abramowicz D, De Meester J, Collart F, Bosmans JL, Cools W, et al. Variability in the incidence of renal replacement therapy over time in Western industrialized countries: A retrospective registry analysis. PLoS One. 2020;15:e0235004. doi: 10.1371/journal.pone.0235004. PubMed PMID: 32584849; PubMed Central PMCID: PMCPMC7316284.
24. Pippias M, Jager KJ, Kramer A, Leivestad T, Sánchez MB, Caskey FJ, et al. The changing trends and outcomes in renal replacement therapy: data from the ERA-EDTA Registry. Nephrol Dial Transplant. 2016;31:831-41. doi: 10.1093/ndt/gfv327. PubMed PMID: 26361801.
25. Grace BS, Clayton P, McDonald SP. Increases in renal replacement therapy in Australia and New Zealand: understanding trends in diabetic nephropathy. Nephrology (Carlton). 2012;17:76-84. doi: 10.1111/j.1440-1797.2011.01512.x. PubMed PMID: 21854505.
26. Haghighi AN, Broumand B, D'Amico M, Locatelli F, Ritz E. The epidemiology of end-stage renal disease in Iran in an international perspective. Nephrol Dial Transplant. 2002;17:28-32. doi: 10.1093/ndt/17.1.28. PubMed PMID: 11773458.
27. Aghighi M, Mahdavi-Mazdeh M, Zamyadi M, Heidary Rouchi A, Rajolani H, Nourozi S. Changing epidemiology of end-stage renal disease in last 10 years in Iran. Iran J Kidney Dis. 2009;3:192-6. PubMed PMID: 19841521.
28. Mahdavi-Mazdeh M, Zamyadi M, Nafar M. Assessment of management and treatment responses in haemodialysis patients from Tehran province, Iran. Nephrol Dial Transplant. 2008;23:288-93. doi: 10.1093/ndt/gfm580. PubMed PMID: 17965435.
29. Hassannia T, Farzadfar F, Noori A, Moradi-Lakeh M, Delavari F, Jamshidi HR, et al. National and sub-national prevalence, trend, and burden of end stage renal diseases (ESRD) in Iran 1990-2013; the study protocol. Arch Iran Med. 2014;17:800-3. PubMed PMID: 25481317.
30. Iseki K, Horio M, Imai E, Matsuo S, Yamagata K. Geographic difference in the prevalence of chronic kidney disease among Japanese screened subjects: Ibaraki versus Okinawa. Clin Exp Nephrol. 2009;13:44-9. doi: 10.1007/s10157-008-0080-3. PubMed PMID: 18854923.
31. Dhoul N, de Lusignan S, Dmitrieva O, Stevens P, O'Donoghue D. Quality achievement and disease prevalence in primary care predicts regional variation in renal replacement therapy (RRT) incidence: an ecological study. Nephrol Dial Transplant. 2012;27:739-46. doi: 10.1093/ndt/gfr347. PubMed PMID: 21677297.
32. Tanner RM, Gutiérrez OM, Judd S, McClellan W, Bowling CB, Bradbury BD, et al. Geographic variation in CKD prevalence and ESRD incidence in the United States: results from the reasons for geographic and racial differences in stroke (REGARDS) study. Am J Kidney Dis. 2013;61:395-403. doi: 10.1053/j.ajkd.2012.10.018. PubMed PMID: 23228944; PubMed Central PMCID: PMCPMC3659181.
33. Castledine CI, Gilg JA, Rogers C, Ben-Shlomo Y, Caskey FJ. How much of the regional variation in RRT incidence rates within the UK is explained by the health needs of the general population? Nephrol Dial Transplant. 2012;27:3943-50. doi: 10.1093/ndt/gfs294. PubMed PMID: 22778180.
34. Wimmer F, Oberaigner W, Kramar R, Mayer G. Regional variability in the incidence of end-stage renal disease: an epidemiological approach. Nephrol Dial Transplant. 2003;18:1562-7. doi: 10.1093/ndt/gfg184. PubMed PMID: 12897095.
35. Ghassemi H, Harrison G, Mohammad K. An accelerated nutrition transition in Iran. Public Health Nutr. 2002;5:149-55. doi: 10.1079/phn2001287. PubMed PMID: 12027278.
